Control of wound healing after glaucoma surgery. Effect and inhibition of the growth factor TGF-beta;Steuerung der wundheilung nach glaukomchirurgie. Wirkung und hemmung des wachstumsfaktors TGF-beta

Ophthalmologe

Volumn 99, Issue 9, 2002, Pages 678-682

  Wimmer, Iris ^a   Grehn, F ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Anti TGF beta antibody; Antimetabolities; Glaucoma; Growth factor; Scarring

Indexed keywords

ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; COLLAGEN; CYTOSINE DEAMINASE; FLUOROURACIL; GELATINASE B; GROWTH FACTOR; MESSENGER RNA; MITOMYCIN C; MONOCLONAL ANTIBODY; PEPTIDE; PLASMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE; PROTEINASE; RIBOZYME; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; VIRUS VECTOR;

AQUEOUS HUMOR; ARTICLE; CLINICAL TRIAL; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GLAUCOMA; HUMAN; OPEN ANGLE GLAUCOMA; SCAR FORMATION; SIDE EFFECT; TRABECULECTOMY; WOUND HEALING;

EID: 0036766189     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-002-0698-6     Document Type: Article

References (27)

1. Ashcroft GS, Yang X, Glick AB, Weinstein M. (1999) Mice lacking Smad 3 show accelerated wound healing and impaired local inflammatory response. Nat. Cell Biol 1:260-266
2. Broadway DC, Migdal CS, Salmon J, Franks WA, Barton K, Khaw PT (2002) Adjunctive anit-TGFβ2 human monoclonal antibody as a novel agent to prevent scarring following phacotrabeculectomy. 2002 ARVO poster 3331
3. Cordeiro MF, Gay JA, Khaw PT (1999). Human anti-transforming growth factor-beta 2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 40:2225-2234
4. Cordeiro MF, Chang L, Lim S, Daniels JT, Pleass RD, Siriwardena D, Khaw PT (2000) Modulating conjunctival wound healing. Eye 14:536-547
5. Heckmann M, Aumailley M, Chu M et al. (1991) Effect of transforming growth factor-b on collagen type VI expression in human dermal fibroblasts. FEBS 310:79-82
6. Ikuno Y, Kazlauskas A (2002) TGFβ1-dependent contraction of fibroblasts is mediated by the PDGFα receptor. IOVS 43:41-46
7. Inatani M, Tanihara H, Katsuta H et al. (2001) Transforming growth factor-b 2 levels in aqueous humor of glaucomatous eyes. Graefess Arch Clin Exp Ophthalmol 239:109-113
8. Jampel HD, Roche N, Stark WJ (1990) Transforming growth factor-beta in human aqueous humor. Curr Eye Res 9:963-969
9. Khaw PT, Cambrey AD, Limb GA, Daniels JT (2002) Gene therapy: new "magic bullets" to prevent ocular scarring. Br J Ophthalmol 86:490-491
10. Khaw PT, Occleston NL, Schultz GS (1994) Activation and suppression of fibroblast function. Eye 8:188-195
11. Kocher O, Madri JA (1989) Modulation of actin mRNA in cultured vasular cells by matrix components and TGF-beta in vitro. Cell Dev Biol 25:424-434
12. Koliakos GG, Schlötzer-Schrehardt, Konstas AGP (2001) Transforming and insulin-like growth factors in the aequeous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 239:482-487
13. Kurosaka D, Nagamoto T (1994) Inhibitory effect of TGF-beta 2 in human aqueous humor on bovine lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 35:3408-3412
14. Madri J, Pratt BM, Tucker AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106:1375-1384
15. Mead AL, Wong TTL, Cordeiro MF, Anderson IK, Khaw PT (2002) Anti-TGFβ2 Antibody (CAT-152) as a new post-operative modulator of scarring after experimental glaucoma filtration surgery. ARVO poster 3332
16. Niesler CU, Ferguson MWJ (2001) TGF-beta superfamily cytokines in wound healing. In: Breit SN,Wahl SM (eds) TGF-beta and related cytokines in inflammation. Birkhauser, Basel, pp 173-198
17. Occleston NL, Tarnuzzer RW, Waters L (1996) Inhibition of matrix metalloproteinases inhibits anterior segment fibroblast mediated collagen contraction. Invest Ophtalmol Vis Sci 31 [Suppl]:S1015
18. Pasquale LR, Dorman Pease ME, Lutty GA et al. (1993) Immunolocalisation of TGF-b1, TGF-b2 and TGF-b3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 34:23-30
19. Picht G, Grehn F (1998) Classification of filtering blebs in trabeculectomy: biomicrospopy and fu nctionality. Curr Opin Ophthalmol 9:11:2-8
20. Roberts AB, Sporn MB (1993) Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9
21. Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal C, Cordeiro MF (2002) Human Anti-transforming growth factor β2 monoclonal antibody - a new modulator of wound healing in trabeculectomy. Ophthalmology 109:427-431
22. Streilein JW (1992) Role of anterior-chamber-associated immune deviation in the pathogenesis of uveitis. Dev Ophthalmolol 23:86-93
23. Tamm ER, Siegner A, Baur A et al.(1996) Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res 62:389-397
24. Tannous M, Hutnik CM, Tingey DP, Mutus B (2000) S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery. Invest Ophthalmol Vis Sci 41:749-755
25. Tripathi RC, Li J, Chan WF, Tripathi BJ (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta. Exp Eye Res 59:723-727
26. Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor beta (TGF-beta) causes a persistent increase in steady state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597-604
27. Wormstone IM, Tamiya S, Anderson I (2002) TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 43:2301-2308